Price (delayed)
$4.46
Market cap
$73.57M
P/E Ratio
10.88
Dividend/share
N/A
EPS
$0.41
Enterprise value
$52.12M
Sensus Healthcare, Inc. is a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for both oncological and non-oncological conditions. The Sculptura™ modulated robotic brachytherapy radiation oncology ...
Highlights
The revenue has soared by 71% YoY
SRTS's debt is down by 23% year-on-year and by 8% since the previous quarter
The gross profit has soared by 74% year-on-year but it has declined by 2.9% since the previous quarter
The net income has declined by 29% since the previous quarter
Sensus Healthcare's EPS has decreased by 28% QoQ
Key stats
What are the main financial stats of SRTS
MarketValuationsEarnings
Shares outstanding
16.5M
Market cap
$73.57M
Enterprise value
$52.12M
Price to earnings (P/E)
10.88
Price to book (P/B)
1.31
Price to sales (P/S)
1.74
EV/EBIT
5.78
EV/EBITDA
5.51
EV/Sales
1.25
Revenue
$41.81M
Gross profit
$24.43M
Operating income
$8.09M
Net income
$6.65M
EBIT
$9.02M
EBITDA
$9.45M
Free cash flow
-$1.11M
Per shareBalance sheetLiquidity
EPS
$0.41
EPS diluted
$0.41
Free cash flow per share
-$0.07
Book value per share
$3.41
Revenue per share
$2.56
TBVPS
$3.81
Total assets
$62.17M
Total liabilities
$6.34M
Debt
$602,000
Equity
$55.83M
Working capital
$50.85M
Debt to equity
0.01
Current ratio
9.64
Quick ratio
7.1
Net debt/EBITDA
-2.27
MarginsEfficiencyDividend
EBITDA margin
22.6%
Gross margin
58.4%
Net margin
15.9%
Operating margin
19.4%
Return on assets
11.2%
Return on equity
12.4%
Return on invested capital
25.7%
Return on capital employed
16%
Return on sales
21.6%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
SRTS stock price
How has the Sensus Healthcare stock price performed over time
Intraday
-8.98%
1 week
-6.5%
1 month
0.22%
1 year
29.65%
YTD
-35.55%
QTD
-5.71%
Financial performance
How have Sensus Healthcare's revenue and profit performed over time
Revenue
$41.81M
Gross profit
$24.43M
Operating income
$8.09M
Net income
$6.65M
Gross margin
58.4%
Net margin
15.9%
SRTS financials
The gross profit has soared by 74% year-on-year but it has declined by 2.9% since the previous quarter
The revenue has soared by 71% YoY
Sensus Healthcare's operating margin has decreased by 33% from the previous quarter
SRTS's operating income is down by 32% QoQ
Growth
What is Sensus Healthcare's growth rate over time
SRTS growth chart
Valuation
What is Sensus Healthcare stock price valuation
P/E
10.88
P/B
1.31
P/S
1.74
EV/EBIT
5.78
EV/EBITDA
5.51
EV/Sales
1.25
Price to earnings (P/E)
Sensus Healthcare's EPS has decreased by 28% QoQ
The price to earnings (P/E) is 10% lower than the last 4 quarters average of 13.3
Price to book (P/B)
SRTS's P/B is 40% below its 5-year quarterly average of 2.4 and 15% below its last 4 quarters average of 1.7
SRTS's equity is up by 14% year-on-year and by 3.1% since the previous quarter
Price to sales (P/S)
The revenue has soared by 71% YoY
The P/S is 42% lower than the 5-year quarterly average of 3.3 and 17% lower than the last 4 quarters average of 2.3
Efficiency
How efficient is Sensus Healthcare business performance
The company's return on invested capital fell by 34% QoQ
Sensus Healthcare's ROA has decreased by 31% from the previous quarter
Sensus Healthcare's ROE has decreased by 31% from the previous quarter
Sensus Healthcare's return on sales has decreased by 31% QoQ
Dividends
What is SRTS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for SRTS.
Financial health
How did Sensus Healthcare financials performed over time
Assets vs liabilities
Sensus Healthcare's total liabilities has increased by 30% YoY and by 11% from the previous quarter
Sensus Healthcare's current ratio has decreased by 18% YoY and by 8% from the previous quarter
Debt vs equity
SRTS's debt is 99% smaller than its equity
Sensus Healthcare's debt to equity has plunged by 50% YoY
SRTS's debt is down by 23% year-on-year and by 8% since the previous quarter
Balance sheet
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from 
and Sharadar.